Table 1.
Clinical and laboratory characteristics of the patients with SLE in the study
| Characteristic | SLE (n = 15) |
|---|---|
| Sex, male/female (n) | 0/15 (15) |
| Age (years), median (range) | 33 (17–57) |
| Duration (months), median (range) | 3 (1–60) |
| SLEDAI score, median (range) | 15 (10–30) |
| ANA > 1:320, yes/no (n) | 15/0 (15) |
| Anti-dsDNA (IU/ml), median (range) | 391.9 (25.9–800) |
| Hypocomplementemia, yes/no (n) | 12/3 (15) |
| Organ involvement, yes/no (n) | 6/9 (15) |
| Steroids, yes/no (n) | 9/6 (15) |
| Immunosuppressive drugs, yes/no (n) | 15/0 (15) |
ANA antinuclear antibody, SLE systemic lupus erythematosus, SLEDAI systemic lupus erythematosus disease activity index